The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sequencing the chemokine receptor CXCR4 in individual circulating tumor cells (CTCs) of patients with breast cancer (BrCa).
F. Fontana
Employment or Leadership Position - Silicon Biosytems
Stock Ownership - Silicon Biosytems
G. Bonizzi
No relevant relationships to disclose
G. Medoro
Employment or Leadership Position - Silicon Biosytems
Stock Ownership - Silicon Biosytems
L. Zorzino
No relevant relationships to disclose
M. Sergio
Employment or Leadership Position - Silicon Biosytems
Stock Ownership - Silicon Biosytems
M. C. Cassatella
No relevant relationships to disclose
E. Peruzzi
Employment or Leadership Position - Silicon Biosytems
S. Gianni
Employment or Leadership Position - Silicon Biosytems
Stock Ownership - Silicon Biosytems
A. Calanca
Employment or Leadership Position - Silicon Biosytems
Stock Ownership - Silicon Biosytems
G. Signorini
Employment or Leadership Position - Silicon Biosytems
Stock Ownership - Silicon Biosytems
F. Nole
No relevant relationships to disclose
G. Giorgini
Employment or Leadership Position - Silicon Biosytems
Stock Ownership - Silicon Biosytems
E. Munzone
No relevant relationships to disclose
N. Manaresi
Employment or Leadership Position - Silicon Biosytems
Stock Ownership - Silicon Biosytems
M. T. Sandri
No relevant relationships to disclose